Insights on Pharmaceuticals & Medical Products

Report

A vision for medical affairs in 2025
– Four core areas of medical-affairs activity combine to maximize patient experiences and outcomes.
Interview

Agile: The new active ingredient in pharma development
– Roche’s Frank Duff and Malte Schutz explain how trust, a faster pace, and evolutionary design have transformed their highly... technical (and highly regulated) work.
Article

Solutions and services in medical devices: White space or white elephants?
– Medical-device players are venturing into adjacent value pools through solutions and services. What do they require to capitalize... on the opportunity and deliver on their profitable growth aspirations?
Article

Biopharma in China: Insights into a market at a crossroads
– Biopharma in China is poised for change that will transform commercial and operating models, and require a step change in capabilities.
Article

Refueling the innovation engine in vaccines
– Vaccine development has slowed over the past five years, but changes to investment strategies and a shift in focus to more technical... and complex vaccines could renew the innovation engine.

Special Collection

Spotlight on Japan
As the world’s second-largest pharma and medtech market, Japan has historically been an innovation center for the industry. But amid an evolving healthcare landscape, this collection of articles and interviews looks at what opportunities and challenges executives at life-sciences companies need to address.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

Learn more

More insights

Interview

Piloting a biotech leader to greater growth
– Growth in a dynamic biotechnology industry requires empowering teams, making real-time adjustments, and shifting the mind-set... to accelerate toward the end goal.
Article

Women in the healthcare industry
– To see how the healthcare sector stacks up on gender equality, we look at employee experiences, policies, and the effectiveness... of industry programs intended to promote diversity and inclusion.
Article

Private equity opportunities in healthcare tech
– Although private equity firms have been hesitant to invest in healthcare tech, they have reason to invest in promising targets... now.
Article

How much is your company worth to its customers?
– Established companies with long histories of performance, increasingly face new competitors with no track record and lower prices.... What’s the value of experience?
Article

What’s next for biosimilars in emerging markets?
– Affordable biologic therapies could help expand patients’ access to treatment in the developing world. Here’s what... pharma companies must know to unlock the potential.
Article

Divestiture in medtech: Are you the natural owner of your businesses?
– For medtech companies, divestitures can create value. But several elements are necessary to make separations successful.
Interview

Transforming Medical Affairs: Tapping the alchemy of storytellers and digital start-ups
– The Head of Digital Strategy and Medical Innovation, US Clinical Development and Medical Affairs at Novartis discusses how disruptive... technologies and digital innovation are inspiring a start-up mind-set within the organization.
Article

Precision medicine: Opening the aperture
– To keep pace with the evolving ecosystem for precision medicine, pharma players must be attuned to three crucial components: data... collection, individualized solutions, and supporting business models.
Interview

How a healthcare company is pursuing agile transformation
– Roche’s head of talent innovation discusses her company’s global leadership initiative.
Interview

Helping to accelerate cures: Regulating the rapidly evolving field of cell and gene therapies
– In this interview, Peter Marks of the US Food and Drug Administration discusses how the organization has contributed to the broader... ecosystem of innovation.
Article

Should sub-Saharan Africa make its own drugs?
– A comprehensive analysis of the business, economic, and public-health impact finds the potential for local production of pharmaceuticals... to be a mixed bag.
Sorry, we couldn't find any results. Try removing some filters.
View more

Related practice

Connect with our Pharmaceuticals & Medical Products Practice

Contact